HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koki Shimizu Selected Research

Fibroma (Fibromatosis)

1/2022Efficacy of auranofin as an inhibitor of desmoid progression.
11/2021Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.
10/2020Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
9/2020Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
9/2020Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.
4/2020Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
12/2019MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
1/2019Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koki Shimizu Research Topics

Disease

8Aggressive Fibromatosis (Desmoid)
01/2022 - 01/2019
8Fibroma (Fibromatosis)
01/2022 - 01/2019
1Headache (Headaches)
07/2021
1Meningitis
07/2021
1Nausea
07/2021
1Bacteremia
07/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2021
1Neutropenia
10/2020
1Pain (Aches)
04/2020
1Acute Kidney Injury (Acute Renal Failure)
07/2016
1Hyponatremia
07/2016

Drug/Important Bio-Agent (IBA)

2CateninsIBA
09/2020 - 01/2019
1Auranofin (Ridaura)FDA Link
01/2022
1liposomal doxorubicin (Doxil)FDA Link
10/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020
1Therapeutic UsesIBA
09/2020
1Pharmaceutical PreparationsIBA
09/2020
1Vinblastine (Vinblastine Sulfate)FDA Link
04/2020
1Methotrexate (Mexate)FDA LinkGeneric
04/2020
1Meloxicam (Mobic)FDA LinkGeneric
12/2019
1SodiumIBA
07/2016
1SolutionsIBA
07/2016

Therapy/Procedure

3Conservative Treatment
11/2021 - 04/2020
2Drug Therapy (Chemotherapy)
10/2020 - 04/2020
1Molecular Targeted Therapy
01/2022
1Activities of Daily Living (ADL)
11/2021
1Maintenance Chemotherapy
07/2021
1Therapeutics
07/2021
1Continuous Renal Replacement Therapy
07/2016